IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 184 filers reported holding IMPAX LABORATORIES INC in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $92,000 | +16.5% | 4,716 | 0.0% | 0.00% | – |
Q4 2017 | $79,000 | -97.3% | 4,716 | -96.8% | 0.00% | -100.0% |
Q3 2017 | $2,946,000 | +10.9% | 145,117 | -12.0% | 0.01% | +9.1% |
Q2 2017 | $2,656,000 | -45.5% | 164,955 | -57.2% | 0.01% | -45.0% |
Q1 2017 | $4,874,000 | -24.5% | 385,326 | -20.9% | 0.02% | -33.3% |
Q4 2016 | $6,458,000 | -43.0% | 487,410 | +1.9% | 0.03% | -44.4% |
Q3 2016 | $11,336,000 | +19.8% | 478,308 | +45.7% | 0.05% | +14.9% |
Q2 2016 | $9,461,000 | +28.3% | 328,280 | +42.6% | 0.05% | +27.0% |
Q1 2016 | $7,373,000 | +16.1% | 230,252 | +55.0% | 0.04% | +19.4% |
Q4 2015 | $6,353,000 | +50.8% | 148,584 | +24.2% | 0.03% | +40.9% |
Q3 2015 | $4,213,000 | +7.1% | 119,661 | +39.7% | 0.02% | +10.0% |
Q2 2015 | $3,934,000 | -6.8% | 85,675 | -4.8% | 0.02% | -4.8% |
Q1 2015 | $4,220,000 | +52.7% | 90,037 | +3.2% | 0.02% | +50.0% |
Q4 2014 | $2,763,000 | +28.5% | 87,203 | -3.9% | 0.01% | +40.0% |
Q3 2014 | $2,151,000 | -72.0% | 90,718 | -64.6% | 0.01% | -73.0% |
Q2 2014 | $7,685,000 | +75.7% | 256,238 | +54.8% | 0.04% | +76.2% |
Q1 2014 | $4,373,000 | – | 165,509 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |